- Home
- FMST vs COSM Comparison
FMST vs COSM Comparison
Compare FMST & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMST
- COSM
- Stock Information
- Founded
- FMST 2005
- COSM 2009
- Country
- FMST Canada
- COSM United States
- Employees
- FMST N/A
- COSM N/A
- Industry
- FMST Other Metals and Minerals
- COSM Other Pharmaceuticals
- Sector
- FMST Basic Materials
- COSM Health Care
- Exchange
- FMST Nasdaq
- COSM Nasdaq
- Market Cap
- FMST 16.8M
- COSM 19.4M
- IPO Year
- FMST N/A
- COSM 2013
- Fundamental
- Price
- FMST $1.40
- COSM $0.86
- Analyst Decision
- FMST
- COSM
- Analyst Count
- FMST 0
- COSM 0
- Target Price
- FMST N/A
- COSM N/A
- AVG Volume (30 Days)
- FMST 19.4K
- COSM 320.4K
- Earning Date
- FMST 01-01-0001
- COSM 11-14-2024
- Dividend Yield
- FMST N/A
- COSM N/A
- EPS Growth
- FMST N/A
- COSM N/A
- EPS
- FMST N/A
- COSM N/A
- Revenue
- FMST N/A
- COSM $56,042,109.00
- Revenue This Year
- FMST N/A
- COSM $4.53
- Revenue Next Year
- FMST N/A
- COSM $25.00
- P/E Ratio
- FMST N/A
- COSM N/A
- Revenue Growth
- FMST N/A
- COSM 13.01
- 52 Week Low
- FMST $1.32
- COSM $0.47
- 52 Week High
- FMST $3.50
- COSM $1.58
- Technical
- Relative Strength Index (RSI)
- FMST 43.67
- COSM 67.69
- Support Level
- FMST $1.32
- COSM $0.51
- Resistance Level
- FMST $1.43
- COSM $0.95
- Average True Range (ATR)
- FMST 0.09
- COSM 0.08
- MACD
- FMST 0.01
- COSM 0.02
- Stochastic Oscillator
- FMST 28.57
- COSM 78.95
About FMST Foremost Lithium Resource & Technology Ltd. Common stock
Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with significant historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.